Venus Concept to Release Second Quarter of Fiscal Year 2023 Financial Results on August 14, 2023
Venus Concept Inc. (NASDAQ: VERO), a global medical aesthetic technology leader, has announced that it will release its second quarter fiscal year 2023 financial results after market close on Monday, August 14, 2023. The company will host a conference call at 5:00 p.m. Eastern Time on the same day to discuss the results and conduct a question and answer session.
Interested parties can participate in the call by dialing 877-407-2991 (201-389-0925 for international callers) and providing the access code 13739854. A live webcast will be available on the company's investor relations website. For those unable to attend, a replay will be accessible for two weeks by calling 877-660-6853 (201-612-7415 for international callers) with the same access code.
Venus Concept Inc. (NASDAQ: VERO), un leader globale nella tecnologia estetica medica, ha annunciato che pubblicherà i suoi risultati finanziari del secondo trimestre dell'anno fiscale 2023 dopo la chiusura del mercato il lunedì 14 agosto 2023. L'azienda ospiterà una conferenza telefonica alle 17:00 ora dell'Est dello stesso giorno per discutere i risultati e condurre una sessione di domande e risposte.
Le parti interessate possono partecipare alla chiamata componendo 877-407-2991 (201-389-0925 per i chiamanti internazionali) e fornendo il codice di accesso 13739854. Una diretta streaming sarà disponibile sul sito web delle relazioni con gli investitori dell'azienda. Per coloro che non possono partecipare, una registrazione sarà accessibile per due settimane componendo 877-660-6853 (201-612-7415 per i chiamanti internazionali) con lo stesso codice di accesso.
Venus Concept Inc. (NASDAQ: VERO), un líder global en tecnología estética médica, ha anunciado que publicará sus resultados financieros del segundo trimestre del año fiscal 2023 después del cierre del mercado el lunes 14 de agosto de 2023. La compañía llevará a cabo una conferencia telefónica a las 5:00 p.m. hora del Este ese mismo día para discutir los resultados y realizar una sesión de preguntas y respuestas.
Las partes interesadas pueden participar en la llamada marcando 877-407-2991 (201-389-0925 para los llamantes internacionales) y proporcionando el código de acceso 13739854. Se dispondrá de una transmisión web en vivo en el sitio web de relaciones con inversionistas de la compañía. Para aquellos que no puedan asistir, se podrá acceder a una grabación durante dos semanas llamando al 877-660-6853 (201-612-7415 para llamadas internacionales) con el mismo código de acceso.
비너스 컨셉 주식회사 (NASDAQ: VERO)는 글로벌 의료 미용 기술 선두주자로서 2023 회계연도 2분기 재무 결과를 2023년 8월 14일 월요일 시장 마감 후 발표할 예정이라고 발표했습니다. 회사는 같은 날 동부 표준시 오후 5시에 결과에 대해 논의하고 질의응답 세션을 진행하기 위해 컨퍼런스 콜을 개최합니다.
관심 있는 당사자는 877-407-2991 (국제 전화는 201-389-0925)로 전화하여 접근 코드 13739854를 제공하면 통화에 참여할 수 있습니다. 회사의 투자자 관계 웹사이트에서 생중계 스트리밍이 제공됩니다. 참여할 수 없는 분들을 위해서, 동일한 접근 코드로 877-660-6853 (국제 전화는 201-612-7415)로 전화하면 2주간 재생을 이용할 수 있습니다.
Venus Concept Inc. (NASDAQ: VERO), un leader mondial dans la technologie esthétique médicale, a annoncé qu'elle publiera ses résultats financiers du deuxième trimestre de l'exercice fiscal 2023 après la fermeture des marchés le lundi 14 août 2023. L'entreprise organisera une conférence téléphonique à 17h00, heure de l'Est le même jour pour discuter des résultats et organiser une session de questions-réponses.
Les parties intéressées peuvent participer à l'appel en composant le 877-407-2991 (201-389-0925 pour les appelants internationaux) et en fournissant le code d'accès 13739854. Un webinaire en direct sera disponible sur le site des relations investisseurs de l'entreprise. Pour ceux qui ne peuvent pas assister, un enregistrement sera accessible pendant deux semaines en appelant le 877-660-6853 (201-612-7415 pour les appelants internationaux) avec le même code d'accès.
Venus Concept Inc. (NASDAQ: VERO), ein globaler Marktführer in der medizinischen Ästhetik-Technologie, hat angekündigt, dass sie ihre Finanzergebnisse für das zweite Quartal des Geschäftsjahres 2023 nach Börsenschluss am Montag, den 14. August 2023 veröffentlichen wird. Das Unternehmen wird am selben Tag um 17:00 Uhr Eastern Time eine Telefonkonferenz abhalten, um die Ergebnisse zu besprechen und eine Frage-und-Antwort-Runde durchzuführen.
Interessierte Parteien können an dem Anruf teilnehmen, indem sie 877-407-2991 wählen (201-389-0925 für internationale Anrufer) und den Zugangscode 13739854 angeben. Ein Live-Webcast wird auf der Investor-Relations-Website des Unternehmens verfügbar sein. Für diejenigen, die nicht teilnehmen können, ist die Aufnahme für zwei Wochen unter 877-660-6853 (201-612-7415 für internationale Anrufer) mit dem gleichen Zugangscode zugänglich.
- None.
- None.
TORONTO, July 05, 2023 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that second quarter of fiscal year 2023 financial results will be released after the market closes on Monday, August 14, 2023.
Management will host a conference call at 5:00 p.m. Eastern Time on August 14, 2023 to discuss the results of the quarter with a question and answer session. Those who would like to participate may dial 877-407-2991 (201-389-0925 for international callers) and provide access code 13739854. A live webcast of the call will also be provided on the investor relations section of the Company's website at ir.venusconcept.com.
For those unable to participate, a replay of the call will be available for two weeks at: 877-660-6853 (201-612-7415 for international callers); access code 13739854. The webcast will be archived at ir.venusconcept.com.
About Venus Concept
Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reach in over 60 countries and 14 direct markets. Venus Concept’s product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Legacy, Venus Velocity, Venus Fiore, Venus Viva, Venus Glow, Venus Bliss, Venus BlissMAX, Venus Epileve, Venus Viva MD and AI.ME. Venus Concept’s hair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. Venus Concept has been backed by leading healthcare industry growth equity investors including EW Healthcare Partners (formerly Essex Woodlands), HealthQuest Capital, Longitude Capital Management, Aperture Venture Partners, and Masters Special Situations.
FAQ
When will Venus Concept (VERO) release its Q2 2023 financial results?
What time is Venus Concept's (VERO) Q2 2023 earnings call scheduled for?
How can investors participate in Venus Concept's (VERO) Q2 2023 earnings call?
Where can I find the webcast for Venus Concept's (VERO) Q2 2023 earnings call?
